
Novel Drug Therapies Could Tackle Treatment-Resistant Depression
An anesthetic, a steroid and a psychedelic are new treatments for a devastating psychiatric disorder
An anesthetic, a steroid and a psychedelic are new treatments for a devastating psychiatric disorder
COVID has jostled people’s emotional equilibrium. Therapy apps, telehealth, lay counselors and psilocybin are poised to change the foundations of caregiving
Businesses must implement wellness programs that are more than just “mindfulness apps, puppies and yoga”
Digital devices can provide better and more useful information than the typical studies conducted with U.S. college students as participants
Psilocybin and MDMA represent a first wave of therapies that help patients by changing the way they view reality
Patterns of word usage in online posts may point to individuals at high risk
A burgeoning industry of apps and wearables must voluntarily put in place standards to ensure its products and services are based on solid evidence for their effectiveness
Education programs in India and New York State teach a basic awareness about stress, anxiety and depression
The global dearth of providers can be addressed with nontraditional methods of teaching new recruits
During COVID, Australia has deployed these tools to forecast the impact of economic and social policies on the country’s mental health
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account